跳至主要内容
临床试验/NCT02038062
NCT02038062已完成不适用

Influence of Sevoflurane Preconditioning on Tissue Oxygenation of the Tibial Anterior Muscle Measured by Near-infrared Spectroscopy After Clamping of the Femoral Artery for Vascular Surgery

University Hospital Schleswig-Holstein2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2010年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
2
主要终点
Decrease of tissue oxygen saturation below 95 % of baseline

研究概览

简要总结

Ischemic preconditioning is defined as protection from cell damage induced by prolonged ischemia by preceding cycles of short ischemia. Hence, ischemic preconditioning could reduce ischemic lesion during clamping a femoral artery for vascular surgery. In this prospective, randomized pilot study is investigated if clamping of the femoral artery leads to ischemia of the calf measurable by near-infrared spectroscopy. In addition to this, the effect of sevoflurane preconditioning on ischemia of the calf is measured.

详细描述

Ischemic preconditioning is performed by clamping of the femoral artery for five minutes in 40 patients. In 20 patients sevoflurane preconditioning is performed five minutes before ischemic preconditioning by inducing sevoflurane anesthesia for five minutes. Muscle tissue oxygenation is measured bilaterally in the anterior tibial muscle by near-infrared spectroscopy (INVOS, SOMANETICS, Troy, Michigan/ USA) during preconditioning and following ischemia.Clinically relevant ischemia was defined as a decrease of tissue oxygen saturation to 95 % of baseline.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • vascular surgery with clamping of a femoral artery. -

排除标准

  • 未提供

研究组 & 干预措施

Sevoflurane

Experimental

Sevoflurane Preconditioning

干预措施: Sevoflurane preconditioning (Procedure)

No Sevoflurane

No Intervention

No Sevoflurane Preconditioning

结局指标

主要结局

Decrease of tissue oxygen saturation below 95 % of baseline

时间窗: 4 hours

Decrease of tissue oxygen saturation below 95 % of baseline

次要结局

未报告次要终点

研究者

发起方
University Hospital Schleswig-Holstein
申办方类型
Other
责任方
Principal Investigator
主要研究者

Axel Fudickar

Dr.

University Hospital Schleswig-Holstein

研究点 (2)

Loading locations...

相似试验